603368.SH
Guangxi LiuYao Group Co., Ltd.
SSE · Healthcare · Medical - Distribution · CN
CNY 16.25
−1.93%Oct 15, 2026, 09:28 UTC
Liuzhou Pharmaceutical Group announced that 475,225 shares under the first tranche of its 2025 employee stock ownership plan became eligible for release from lock-up, representing 0.12% of its total share capital and involving 30 holders.
Source:Sep 1, 2026, 10:12 UTC
Liuzhou Pharmaceutical Group announced its first-half 2026 results: revenue of 10.526 billion yuan, up 2.19% year-on-year, and net profit attributable to shareholders of 369 million yuan, down 14.00% year-on-year.
Source: